Robert Cavaliere MD


​ 

Robert Cavaliere MD
Asst Professor - ClinicalCollege of Medicinecavaliere.4@osu.edu
Starling Loving Hall 320 W 10th Avenue Columbus Ohio 43210
Phone:614-293-4448Fax: 614-366-5763
  • Viral Oncology

General Research Interest

Primary and metastatic brain cancer, quality of life outcomes, experimental therapeutics.

Research Description

• The development of therapies for patients with metastatic and primary brain tumors that prolong and improve their lives. • The evaluation of the processes and treatments currently employed for their true effectiveness and impact on quality of life. • The study of certain high-risk populations (including the elderly and those significantly impaired by their disease) in which the small gains of treatment must be balanced against the increased risk of treatment toxicity and complications.

Transinstitutional Work

Collaboration of all members of the neuro-oncology treatment team, including medical neuro-oncology, neurosurgery and radiation oncology, is critical to the successful delivery of care. For this reason, a multidisciplinary neuro-oncology clinic was established at The James to accommodate patients with such complex diseases. The development of novel therapies to treat brain cancers requires close collaboration with basic scientists, in whose labs drugs are first conceived and tested. Through this partnership, promising agents are identified and translated into clinical studies for patients. Successful care requires team members to address the daily needs of patients: psychological, financial, physical and social needs. Our neuro-oncology nurses, social workers and counselors focus all their attention on these needs.

Current Publications

  • Kendra KLRadiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib.Melanoma Res 24 172-6 4/1/2014
  • Phelps MADevelopment and validation of sensitive liquid chromatography/tandem mass spectrometry method for quantification of bendamustine in mouse brain tissue.J Chromatogr B Analyt Technol Biomed Life Sci 905 9/15/2012
  • Hafeez S, Cavaliere RRecent innovations in the management of low-grade gliomas.Curr Treat Options Neurol 14(4) 369-80 8/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu